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and evaluation of a derivative recombinant adenovirus 
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 (Children's Hospital of Chongqing Medical University, Chongqing, China) 
 
Abstract  
We found a novel gene named as HA117 in our previous research. At this study, we screened 
for an optimal siRNA targeting the novel gene HA117 using the pSOS-HUS method, verified 
the results of pSOS-HUS siRNA screening for optimal affinity for the target gene, and 
constructed and evaluated a recombinant adenovirus carrying the DNA template for 
transcription of the optimal HA117 siRNA. The pSOS-HUS vector method was successfully 
utilized as a rapid and effective screen for an optimal siRNA for a target gene. Among five pairs 
of DNA templates, siRNA transcribed from HAi5 gave the strongest interference with the 
novel gene HA117; a HAi5-carrying recombinant adenovirus (Ad-HAi5) was successfully 
constructed and evaluated, laying a foundation for the further study of HA117 gene function 
with RNAi technology. 
Keywords: HA117 gene; RNA interference; screening; multidrug resistance; recombinant 
adenovirus 
The development of multidrug-resistant tumor cells is a complex process regulated by multiple 
genes. In a previous study, we established a multidrug-resistant cell line (HL-60/MDR) to 
facilitate the search for genes involved in the regulation of tumor-cell multidrug resistance 1. 
With a combination of suppression, subtractive hybridization and microarray methods, we 
screened and cloned the novel gene HA117 (Genbank accession number AY230154), which 
was clearly expressed in the drug-resistant HL60/MDR cell line but not expressed in wild-type 
HL60 cells. And we found it increased the multidrug resistance of K562 cells and CW-2 cells 
and could be one of genes regulating tumor cells’ drug resistance and a new target of cancer 
gene therapy2. In the present study, we used the plasmid-based pSOS-HUS screening system 
previously developed in our laboratory to screen for siRNAs targeting the HA117 gene 3.  
Double-cloned plasmids were constructed containing both the HA117 gene and DNA templates 
for complementary siRNA. After transfection of the double-cloned plasmids into 293 cells, we 
screened for and identified an optimal siRNA for the HA117 gene by measuring green 
fluorescent protein (GFP) expression levels via microscopic observation and flow cytometry 
and by quantitating HA117 mRNA expression by everse-transcription qPCR” (RT-qPCR). A 
recombinant adenovirus for HA117 RNA interference was then constructed and evaluated. 
Materials and methods 
Plasmids and cell lines  
The screening plasmid pSOS-HUS and a red fluorescent protein (RFP)-carrying adenovirus 
backbone plasmid (pSES-HUS) were developed in collaboration between our laboratory and 
the Molecular Oncology Laboratory of the University of Chicago. E. coli DH5α, E. coli 
BJ5183 and its derivative Adeasy-1 cells, the adenoviral-genome-carrying plasmid pAdeasy-1 
and the packaging cell line 293 were generous gifts from Professor Tong-Chuan He of the 
Molecular Oncology Laboratory of the University of Chicago. The HA117 gene-carrying 
recombinant plasmid pAdtrack-HA117 and the recombinant adenovirus Ad5-HA117 were 
propagated in our laboratory 4. The human colon carcinoma cells CW-2 were bought from the 
Cell Bank of Chinese Academy of Science, Shanghai, China. 
Reagents  
Restriction endonucleases, T4 DNA ligase, plasmid DNA isolation, extraction and purification 
kits and RT-PCR kits were all purchased from TaKaRa Bio Inc. Lipofectamine and an 
RNA-extraction kit were purchased from Invitrogen Corporation. DNA templates for HA117 
gene siRNAs and PCR primers were synthesized by TaKaRa Bio Inc. DNA sequencing was 
conducted by the Laboratory of Infectious Diseases at Chongqing Medical University. 
High-quality fetal bovine serum and 1640 medium were Gibco products. 
Construction of recombinant plasmid pSOS-HUS-HA117   
The plasmids pAdTrack-HA117 and pSOS-HUS were double-digested with HindIII and KpnI 
restriction endonucleases. The excised target gene, HA117, and the linearized pSOS-HUS 
vector were extracted from an agarose gel after digestion, then purified, ligated with T4 DNA 
ligase and transformed into competent DH5 cells. Colonies were picked and amplified for 
plasmid DNA preparation and restriction digestion. Positive clones were identified by 
restriction digestion and further confirmed by sequencing. 
Design and synthesis of DNA templates for HA117 siRNA 
Based on the principles of siRNA design and the full-length cDNA sequence of the HA117 
gene5, we designed specific HA117 gene-insertion-fragment sequences for synthesis. These 
were designated as follows. HAi1: sense strand, 5'-aCGACAGTATCAACATATCAtttt-3'; 
antisense strand, 5’-aTTCTCAGCTGGACCATCTGtttt-3; HAi2: sense strand, 
5’-aATACGGAGATACGACAGTAtttt-3'; antisense strand, 5'-aTACTG 
TCGTATCTCCGTATtttt- 3'; HAi3: sense strand, 5'-aCGACAGTATCAACATATCAtttt-3'; 
antisense strand, 5'-aTGATATGTTGATACTGTCGtttt-3’; HAi4: sense strand, 
5'-aTTATGGACCTGAGGCAGATtttt-3'; antisense strand, 
5'-aATCTGCCTCAGGTCCATAAttt-3'; HAi5: sense strand, 
5'-aGCACCTGAGTACAGACAATtttt-3';antisense strand, 
5'-aATTGTCTGTACTCAGGTGCtttt-3'. The lowercase letters indicate sequences 
complementary to the cohesive ends of the SfiI-digested pSOS-HUS plasmid. 
Construction and identification of the pSOS-HUS-HA117 and HAi recombinant plasmids  
Plasmid pSOS-HUS-HA117 was digested with SfiI, ligated to the five pairs of DNA 
templates with T4 DNA ligase and transformed into DH5α competent cells. Colonies 
were picked and amplified for plasmid DNA preparation and restriction digestion. 
Positive clones were identified by restriction digestion and further confirmed by 
sequencing. 
Transfection of the double-cloned plasmids into 293 cells with Lipofectamine   
The plasmid pSOS-HUS-HA117 and the five positive double-cloned plasmids were extracted 
and dissolved in a final volume of 30 μL. The OD values at A260 nm of the samples of HAi1– 
HAi5 were measured by spectrophotometer at 7.78, 7.32, 9.45, 8.33, 7.96 and 8.57, 
respectively. The amount of each plasmid solution needed for transfection was calculated to 
provide 4 μg DNA; therefore the DNA volumes of the double-cloned plasmids HAi1– HAi5 
used for transfection were 10.5, 11, 8.5, 9.7, 10 and 9.6 μL, respectively. The packaging 293 
cells were cultured in RPM1640 medium containing 10% fetal bovine serum in a 37°C 
incubator with 5% CO2. Exponentially growing cells were seeded into six 50-mL cell culture 
flasks to 50-60% confluence. These 293 cells were incubated for 14 hours before being 
transfected with the quantified recombinant pSOS-HUS-HA117 plasmid or one of the five 
double-cloned plasmid DNAs with Lipofectamine. At 24 hours after transfection, relative GFP 
expression levels were determined by fluorescence microscopy and flow cytometry. 
Measurement of HA117 mRNA expression in the transfected 293 cells by RT-qPCR  
Six flasks of pSOS-HUS-HA117- or double-cloned plasmid-transfected 293 cells were 
harvested at 24 hours post-transfection. Total RNA was isolated and amplified by RT-PCR. For 
the β-actin internal control, the upstream primer was 5′-CTTTGGTATCGTGGAAGGACTC-3′ 
and the downstream primer was 5′-AGTGGGTGTCGCTGTTGAAGT-3′. For the target gene, 
the upstream primer was 5′-CAGAGTCAGGGACTTCAGCCTTAT-3′ and the downstream 
primer was 5′-CTGTTTCCTTCTCACTCCCAACCA-3′. The amplification conditions were: 
94°C for 5 min, 94°C for 30 s, 68°C for 30 s and 72°C for 1 min, for a total of 35 cycles, 
followed by 72°C for 7 min. The amplification products were separated by agarose-gel 
electrophoresis and visualized with a UV transilluminator. 
Generation of recombinant adenovirus carrying DNA template of the optimal siRNA against 
HA117   
The adenovirus backbone plasmid pSES-HUS was digested with SfiI, ligated to the selected 
optimal siRNA template (HAi) and transformed into DH5α competent cells. Colonies were 
picked  and screened by restriction digestion. A positive clone of pSES-HUS-HAi was verified 
by sequencing. The pSES-HUS-HAi plasmid was linearized with PmeI and cotransformed with 
the adenoviral homologous shuttle plasmid BJ-Adeasy. The recombinants were identified by 
PacI digestion. A positive clone was transformed into DH5α competent cells and further 
confirmed with PacI digestion. The recombinant adenoviral plasmid was linearized and 
transfected into 293 cells with Lipofectamine for packaging. At 25-30 d post-transfection 
(when most cells were floating), all cells were harvested and subjected to three freeze-thaw 
cycles using dry ice. The virus-containing supernatant was collected and used to infect 293 
cells for recombinant adenovirus amplification. The infection cycle was repeated three times to 
generate a high titer of Ad5-HAi5 adenovirus, which was kept at -80°C as a viral stock 6. 
Evaluation of HA117 gene silencing by the recombinant-RNA interference adenovirus 
Ad-HAi5   
The CW-2 cells were infected with the recombinant adenovirus carrying the HA117 gene. At 
24 hours post-infection, the infected cells were divided into two groups, a control group and an 
RNAi group. The RNAi group of CW-2 cells was infected with the 
recombinant-adenovirus-carrying siRNA. The CW-2 cells not infected with recombinant 
adenovirus were used as a control. After 48 hours of incubation, two groups of cells were 
harvested, their total RNAs were extracted and the cellular HA117 mRNA expression levels 
were determined by RT-qPCR. 
Statistical analysis 
The experimental data were subjected to analysis of variance, with p <0.05 being considered 
statistically significant. 
Results 
Restriction digestion of recombinant plasmid pSOS-HUS-HA117 
The successfully constructed recombinant plasmid pSOS-HUS-HA117 was double-digested 
with HindIII and KpnI. The circular plasmid was cleaved into a 4.9-kb pSOS-HUS DNA 
fragment and a 1.19-kb HA117 gene fragment, as shown in Figure 1. 
Restriction digestion of the double-cloned pSOS-HUS-HA117-HAi plasmid 
The plasmid pSOS-HUS has a SfiI restriction site between the U6 and H1 promoters. This site 
is lost after SfiI digestion and all HAi fragments cloned into this site would not have the SfiI 
restriction site. Therefore, plasmids with positive clones cannot be digested with SfiI 4. The 
double-cloned pSOS-HUS-HA117-HAi1 plasmid was digested with SfiI and the uncut, 
supercoiled-plasmid DNA band could be seen after electrophoresis. HindIII- and KpnI-double 
digestion of pSOS-HUS-HA117-HAi1 released a 1.19-kb HA117 band and a 4.9-kb vector 
band. These results indicated that pSOS-HUS-HA117-HAi1 carried both the HA117 gene and 
its RNAi fragment, as shown in Figure2. 
Sequence verification of the double-cloned plasmids 
Each of the five correct double-cloned plasmids was submitted for DNA sequencing. The U6 
promoter on the plasmid was used as the starting point to sequence the DNA between the H1 
and U6 promoters. The results showed that the sequences between the H1 and U6 promoters 
corresponded to the HAi sequence, confirming that the five double-cloned plasmids were 
successfully constructed, as shown in Figure 3. 
Relative GFP expression levels in transfected 293 cells 
The transfected 293 cells were observed and compared at 24 hours post-transfection. The green 
fluorescence was the weakest in the HAi5-containing 293 cells. All groups of cells were 
harvested to examine the percentage of GFP-expressing cells by flow cytometry. The data were 
analyzed with the Chi-square test. The 293 cells transfected with the HAi5-containing 
double-cloned plasmid had the lowest ratio of GFP expression, which was consistent with the 
fluorescence-microscopy results. These results suggested that the siRNA transcribed from 
HAi5 had the strongest ability to interfere with HA117, as shown in Figure 4 and Table 1. 
HA117 mRNA expression in the transfected 293 cells 
At 24 hours after transfection, the six groups of transfected 293 cells were harvested and the 
HA117 mRNA expression levels in the different groups were determined by RT-PCR. The 
PCR products were separated by 2%-agarose-gel electrophoresis and visualized under a UV 
transilluminator. The HA117 mRNA expression level was the lowest in the group of 293 
cells transfected with pSOS-HUS-HA117-HAi5, suggesting that the siRNA transcribed from 
HAi5 had the strongest ability to interfere with HA117 gene expression, as shown in Figure 
5.  
Restriction digestion of the recombinant adenoviral plasmid Adeasy-HAi5 
After HAi5 was cloned into the adenovirus backbone plasmid pSES-HUS, it was 
cotransformed with the adenovirus homologous shuttle plasmid Adeasy for recombination. 
After a successful recombination event, the plasmid digested with PacI should generate 4.5-kb 
and 23-kb DNA bands. The results shown in Figure 6 indicated a successful recombination. 
Infection of 293 packaging cells with Ad-HAi5 recombinant adenovirus to generate 
high-titer virus 
The recombinant adenovirus plasmid Adeasy-HAi5 was transfected into 293 cells for viral 
packaging. Under fluorescence microscopy, red fluorescence was observed at 24 hours 
post-transfection in the transfected 293 cells, indicating a successful transfection. Subsequently, 
the intensity of the red fluorescence gradually increased with time. Simultaneously, the cells 
gradually transitioned from adhesive growth into a floating condition, suggesting the successful 
packaging of infectious, intact Ad-HAi5 recombinant adenoviral particles. The process took 
about four weeks, as shown in Figure 7. 
The Ad-HAi5 recombinant adenovirus effectively silences HA117 gene expression 
CW-2 cells are highly susceptible to the recombinant adenoviruses Ad-HA117 and 
Ad-HAi5. At 48 hours postinfection, green fluorescence was observed in CW-2 cells 
infected with Ad-HA117. At 24 hours after Ad-HA117 infection, the infected CW-2 
cells were superinfected with Ad-HAi5, and both green and red fluorescence were 
observed simultaneously, as shown in Figure 8. 
Forty-eight hours later, all groups of cells were harvested and analyzed by RT-qPCR. 
The Ad-HA117-infected control cells showed a 119-bp DNA band characteristic of the 
HA117 gene, indicating that exogenous HA117 was effectively expressed in 
Ad-HA117 infected CW-2 cells. The RNAi group cells infected with Ad-HA117 then 
superinfected with Ad-HAi5 did not show the DNA band for the HA117 gene, 
suggesting that the HA117-targeting RNAi successfully silenced the exogenous 
HA117 gene expression in the CW-2 cells, as shown in Figure 9.  
3. Discussion 
RNAi silencing is posttranscriptional gene silencing mediated by siRNAs. It features high 
specificity, high efficiency and inheritability and it is an effective method for studying gene 
function 7,8.  Currently, siRNAs are usually designed based on software analysis or literature 
study. Different software-designed siRNAs targeting the same gene may have different 
interference efficiencies 9-11. Therefore, if the most efficient siRNA can be quickly and easily 
screened from among many siRNAs, this would greatly facilitate subsequent successful 
silencing of target gene expression with RNAi; this capability would be especially helpful in 
the study of novel gene function. 
The convenient and effective siRNA screening plasmid (pSOS-HUS) used in this study is a 
vector system developed by our group in collaboration with the Cancer Research Institute at 
the University of Chicago to express small RNA fragments as RNAi 3. This vector contains 
two parts: one is a fusion protein of the target-gene product and green fluorescent protein 
(GFP) and the other is a transcription unit for a 19–21-nt, double-stranded, small RNA 
fragment (siRNA) under the control of both the U6 and H1 promoters. If this 19–21-nt 
sequence is completely complementary to a fragment of the target gene, the target gene will 
be silenced based on the RNA-interference principle. The silencing effect can be directly 
monitored under a fluorescence microscope by examining the reduction or loss of GFP 
expression. 
The siRNA for RNAi can be obtained by in vitro preparation (such as chemical synthesis), 
in vitro transcription or by digesting a large dsRNA fragment using RNase III. It can also be 
obtained by in vivo synthesis through siRNA expression using plasmid or viral vectors, or 
through a siRNA expression cassette prepared by PCR 12. Among these cassettes, the 
adenoviral vector for intracellular siRNA expression is convenient and inexpensive; making it 
one of the most widely used biological viral vectors. It has many advantages including a wide 
host range, low pathogenicity for humans and effective proliferation 13-16. Here, we used the 
adenoviral shuttle plasmid pSES-HUS to design a double promoter containing a SfiI 
restriction site. Upon insertion of the siRNA transcription template of the target gene into this 
site, the siRNA can be made. Based on this shuttle plasmid and the adenoviral backbone 
plasmid, a recombinant RNA-interference adenovirus was constructed for the target gene. 
After infecting the cells, siRNA for the target gene was stably expressed for a long period of 
time as it executed its RNAi function.  
Using the screening plasmid pSOS-HUS, we successfully identified the strongest-interfering 
siRNA (HAi5) from among five siRNA transcription templates for the target gene HA117, 
and we constructed an HAi5-carrying recombinant adenovirus (Ad-HAi5) to target HA117 
using the modified adenovirus shuttle plasmid pSES-HUS. Subsequent functional analysis 
showed that Ad-HAi5 effectively silenced HA117 gene expression through RNA interference. 
This study thus established a framework for further functional studies of the novel gene 
HA117 using RNA interference. Additionally, our results showed that pSOS-HUS is a quick 
and convenient screening system for selecting the best siRNA transcription template for a 
target gene.  
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Table1   GFP expression in transfected 293 cells 
Groups Number of cells 
expressing GFP 
Number of cells not 
expressing GFP 
Total number 
of cells 
Percentage of cells expressing 
GFP (%) 
Control  1.72×107 0.88×10 2.60×107 66.23 
HAi1 1.65×107 1.69×107 3.34×107 49.57 
HAi2   0.79×107 1.26×107 2.05×107 38.73 
HAi3 0.23×107 2.52×107 2.75×107 8.49 
HAi4 0.60×107 3.30×107    3.90×107 15.42 
HAi5     0.03×107 2.35×107   2.38×107 1.36 
Notice：vs other groups, the GFP proportion of cells with pSOS-HUS-HA117-HAi5 
transfected was lowest, P＜0.05.  
 
